Differences in physicians' understanding of biologic and biosimilar medicines in the USA and Europe

被引：0
|
作者：
Molinari, A. L.
Gewanter, H. L.
Reilly, M.
Charles, D.
机构：
来源：
MOVEMENT DISORDERS | 2016年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1804
引用
收藏
页码：S595 / S596
页数：2
相关论文
共 50 条
  • [1] DIFFERENCES IN PRICING POLICIES FOR GENERIC AND BIOSIMILAR MEDICINES
    Vogler, S.
    Schneider, P.
    Gombocz, M.
    Zimmermann, N.
    VALUE IN HEALTH, 2016, 19 (07) : A350 - A350
  • [2] Global survey of physicians' attitudes toward biologic and biosimilar therapies
    Molinari, Anna L.
    Gewanter, Harry L.
    Loaiza-Bonilla, Arturo
    Reilly, Michael
    Kennedy, Brian
    Charies, David
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [3] Biosimilar medicines used for cancer therapy in Europe: a review
    Santos, Sofia B.
    Sousa Lobo, Jose M.
    Silva, Ana C.
    DRUG DISCOVERY TODAY, 2019, 24 (01) : 293 - 299
  • [4] Key concepts in biosimilar medicines: What physicians must know
    Iskit, Alper B.
    NORTHERN CLINICS OF ISTANBUL, 2022, 9 (01) : 86 - 91
  • [5] Patenting personalized medicines in the UK, Europe and USA
    Parker, Scott
    Hall, Ben
    PHARMACEUTICAL PATENT ANALYST, 2014, 3 (02) : 163 - 169
  • [6] THE COST SAVING POTENTIAL OF UTILIZING BIOSIMILAR MEDICINES IN BIOLOGIC NAIVE SEVERE RHEUMATOID ARTHRITIS PATIENTS
    Whitehouse, J.
    Walsh, K.
    Papandrikopoulou, A.
    Hoad, R.
    VALUE IN HEALTH, 2013, 16 (07) : A573 - A573
  • [7] Biosimilar medicines: impact, opportunities and strategies. Twelve years of experience in Europe
    Delgado Sanchez, Olga
    Ginard Vicens, Daniel
    Sampol Mayol, Antonia
    Terrasa Pons, Josefa
    MEDICINA CLINICA, 2019, 152 (10): : 411 - 415
  • [8] Assessing awareness and attitudes of healthcare professionals on the use of biosimilar medicines: A survey of physicians and pharmacists in Ireland
    O'Callaghan, Joan
    Bermingham, Margaret
    Leonard, Maurice
    Hallinan, Frank
    Morris, J. Michael
    Moore, Una
    Griffin, Brendan T.
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2017, 88 : 252 - 261
  • [9] Preparing for a new generation of biologic therapies: understanding the development and potential of biosimilar cancer therapeutics
    Coiffier, Bertrand
    FUTURE ONCOLOGY, 2017, 13 (15) : 1 - 3
  • [10] Differences and opportunities of THA in the USA, Asia and Europe
    Kiefer, H.
    Bioceramics and Alternative Bearings in Joint Arthroplasty, 2007, : 3 - 8
12345